Prudential Financial Inc Day One Biopharmaceuticals, Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$12.03 - $17.69 $1.77 Million - $2.6 Million
-146,930 Reduced 86.67%
22,592 $311,000
Q1 2024

May 14, 2024
BUY
$13.56 - $17.46 $2.3 Million - $2.96 Million
169,522 New
169,522 $2.8 Million
Q3 2022

Nov 04, 2022
BUY
$16.44 - $26.57 $629,898 - $1.02 Million
38,315 New
38,315 $767,000
Q1 2022

May 13, 2022
SELL
$9.12 - $17.47 $127,087 - $243,444
-13,935 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$15.65 - $26.33 $218,082 - $366,908
13,935 New
13,935 $235,000

Others Institutions Holding DAWN

# of Institutions
178
Shares Held
84M
Call Options Held
144K
Put Options Held
218K
View Full List

About Day One Biopharmaceuticals, Inc.

DAWN Quotes by TradingView
  • Ticker DAWN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,461,104
  • Market Cap $1.01B
  • Description
  • Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...
More about DAWN
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email